{
    "drug_class_values": "alkyl sulfonates , cd22 (clusters of differentiation 22) inhibitors , egfr (epidermal growth factor receptor) inhibitors , detoxifying agents for antineoplastic treatment , other antithrombotic agents , cd38 (clusters of differentiation 38) inhibitors , various therapeutic radiopharmaceuticals , enzymes , other hematological agents , other immunostimulants , various alimentary tract and metabolism products , antivirals , epidermal growth factor receptor (egfr) tyrosine kinase inhibitors , bcr-abl tyrosine kinase inhibitors , other immunosuppressants , selective immunosuppressants , other plant alkaloids and natural products , other hormone antagonists and related agents , preparations increasing uric acid excretion , other protein kinase inhibitors , vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors , proteasome inhibitors , anti-androgens , antineoplastic cell and gene therapy , fourth-generation cephalosporins , vegf/vegfr (vascular endothelial growth factor / -receptor) inhibitors , cd20 (clusters of differentiation 20) inhibitors , anti-estrogens , nan , antineovascularisation agents , her2 (human epidermal growth factor receptor 2) inhibitors , other monoclonal antibodies and antibody drug conjugates , hedgehog pathway inhibitors , other antianemic preparations , combinations of antineoplastic agents , pd-1/pd-l1 (programmed cell death protein 1/death ligand 1) inhibitors , combinations of monoclonal antibodies and antibody drug conjugates , anaplastic lymphoma kinase (alk) inhibitors , b-raf serine-threonine kinase (braf) inhibitors , poly (adp-ribose) polymerase (parp) inhibitors , fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors , phosphatidylinositol-3-kinase (pi3k) inhibitors , other antineoplastic agents , pyrimidine analogues , janus-associated kinase (jak) inhibitors , bruton's tyrosine kinase (btk) inhibitors , cyclin-dependent kinase (cdk) inhibitors , colony stimulating factors , isocitrate dehydrogenase (idh) inhibitors , other drugs affecting bone structure and mineralization , aromatase inhibitors , monoclonal antibodies , interleukin inhibitors , interferons , human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors , histone deacetylase (hdac) inhibitors , mitogen-activated protein kinase (mek) inhibitors, Agents for dermatitis, excluding corticosteroids, Janus-associated kinase (JAK) inhibitors, Other systemic drugs for obstructive airway diseases, Calcitonin gene-related peptide (CGRP) antagonists, Selective serotonin (5HT1) agonists"
    ,"drug_indication_values":  "endometrial cancer , epithelioid sarcoma , polyarticular juvenile idiopathic arthritis , non-myeloid malignancies , spinal muscular atrophy , giant cell arteritis , bone loss due to androgen deprivation therapy , aggressive systemic mastocytosis , carcinoid syndrome diarrhea , epithelial ovarian cancer , chronic myeloid leukemia , coronavirus disease 2019 , severe asthma , triple-negative breast cancer , eosinophilic granulomatosis with polyangiitis , peripheral t-cell lymphoma , acute lymphoblastic leukemia , acute myeloid leukemia , kaposi sarcoma , diabetic macular edema , psoriatic arthritis , solid tumors , non-muscle invasive bladder cancer , nonmuscle invasive bladder cancer , cognitive impairment , follicular lymphoma , pediatric low-grade glioma , hematopoietic subsyndrome of acute radiation syndrome , light chain (al) amyloidosis , macular edema , friedreich's ataxia , osteoporosis , myelofibrosis , eosinophilic esophagitis , plaque psoriasis , ankylosing spondylitis , chronic lymphocytic leukemia / small lymphocytic lymphoma , hematopoietic syndrome of acute radiation syndrome , chronic rhinosinusitis with nasal polyps , glucocorticoid-induced osteoporosis , gastroenteropancreatic neuroendocrine tumors , medullary thyroid cancer , bladder cancer , differentiated thyroid cancer , merkel cell carcinoma , diffuse large b-cell lymphoma , duchenne muscular dystrophy , colorectal cancer , hereditary transthyretin-mediated amyloidosis , malignant pleural mesothelioma , nonmyeloid malignancies , multicentric castleman's disease , waldenström's macroglobulinemia , tumor mutational burden-high solid tumors , squamous cell carcinoma of the oral cavity , neovascular age-related macular degeneration , hepatic veno-occlusive disease (vod) / sinusoidal obstruction syndrome (sos) , myelodysplastic syndromes with ring sideroblasts or myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis , non-small cell lung cancer , gastric or gastroesophageal junction adenocarcinoma , blastic plasmacytoid dendritic cell neoplasm , esophageal cancer , polymyalgia rheumatica , systemic mastocytosis with associated hematological neoplasm , microsatellite instability-high or mismatch repair deficient solid tumors , indolent systemic mastocytosis , granulomatosis with polyangiitis and microscopic polyangiitis , metastatic renal cell carcinoma , uveal melanoma , methotrexate toxicity , marginal zone lymphoma , non-radiographic axial spondyloarthritis , chronic myelogenous leukemia , chronic obstructive pulmonary disease , enthesitis-related arthritis , renal cell carcinoma , thyroid cancer , hidradenitis suppurativa , diabetic retinopathy , cutaneous t-cell lymphoma , prostate cancer , neuromyelitis optica spectrum disorder , microsatellite instability-high or mismatch repair deficient colorectal cancer , autologous hematopoietic progenitor cell mobilization , rheumatoid arthritis , prurigo nodularis , small cell lung cancer , urothelial cancer , glioblastoma , anaplastic thyroid cancer , alveolar soft part sarcoma , neuroblastoma , coronary artery disease , advanced systemic mastocytosis , cervical cancer , mismatch repair deficient recurrent or advanced solid tumors , chronic graft-versus-host disease , squamous cell carcinoma of the head and neck , chronic lymphocytic leukemia or small lymphocytic lymphoma , gastrointestinal stromal tumor , bone loss due to aromatase inhibitor therapy , pheochromocytoma or paraganglioma , histiocytic neoplasms , leiomyosarcoma , uncomplicated urinary tract infection , asthma , waldenström’s macroglobulinemia , myeloid/lymphoid neoplasms , bullous pemphigoid , mast cell leukemia , philadelphia chromosome-positive acute lymphoblastic leukemia , myelodysplastic syndromes , metastatic gastric adenocarcinoma , beta thalassemia , hepatocellular carcinoma , non-squamous non-small cell lung cancer , alzheimer's disease , migraine , cluster headache , grade 2 astrocytoma or oligodendroglioma , chronic lymphocytic leukemia/small lymphocytic lymphoma , breast cancer , b-cell precursor acute lymphoblastic leukemia , multiple sclerosis , biliary tract cancer , giant cell tumor of bone , transthyretin-mediated amyloidosis , crohn's disease , basal cell carcinoma , head and neck squamous cell carcinoma , gastric cancer , cholangiocarcinoma , bone metastases from solid tumors , neuroendocrine tumors , urothelial carcinoma , acute leukemia , diffuse large b-cell lymphoma and high-grade b-cell lymphoma , crohn’s disease , esophageal squamous cell carcinoma , β-thalassemia , synovial sarcoma , multiple myeloma , melanoma , chronic lymphocytic leukemia , gastric or gastro-esophageal junction adenocarcinoma , von hippel-lindau disease , sickle cell disease , systemic juvenile idiopathic arthritis , ovarian cancer , atopic dermatitis , pancreatic cancer , cytokine release syndrome , achondroplasia , chronic spontaneous urticaria , endometrial carcinoma , squamous non-small cell lung cancer , solid tumors with ntrk gene fusion , non-myeloid malignancy , lymphoblastic lymphoma , low-grade glioma , high-risk smoldering multiple myeloma , small lymphocytic lymphoma , nasopharyngeal carcinoma , large b-cell lymphoma , hypercalcemia of malignancy , squamous cell carcinoma of the anal canal , pemphigus vulgaris , episodic migraine , metastatic colorectal cancer , neurofibromatosis type 1 , non-hodgkin's lymphoma , myelodysplastic syndrome , recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer , acute graft versus host disease , cutaneous squamous cell carcinoma , beta-thalassemia , hypereosinophilic syndrome , advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer , liposarcoma , lupus nephritis , ulcerative colitis , severe chronic neutropenia , desmoid tumor , polycythemia vera , lung cancer , tenosynovial giant cell tumor , mantle cell lymphoma"
    ,"drug_manufacturer_values": "Pfizer Inc., Teva Pharmaceuticals USA, Sportpharm, Inc. dba Sportpharm, Allergan, Inc., Lundbeck Pharmaceuticals LLC, Inc., mirati therapeutics, inc, exelixis, inc., acrotech biopharma inc, tanvex biopharma usa, inc., bluebird bio, inc., kadmon pharmaceuticals, llc, geron corporation, astellas pharma us, inc., organon llc, blueprint medicines corporation, coherus biosciences, inc., fresenius kabi usa, llc, blue earth diagnostics, beone medicines usa, inc., secura bio, inc, emd serono, inc., ge healthcare inc. (medi-physics, inc. dba ge healthcare), tg therapeutics, inc., united therapeutics corporation, boehringer ingelheim pharmaceuticals, inc., genzyme corporation, g1 therapeutics, inc., amgen inc, novartis gene therapies, inc., medexus pharma, inc., adc therapeutics america, inc., janssen products, lp, incyte corporation, regeneron pharmaceuticals, inc, takeda pharmaceuticals america, inc., eli lilly and company, astrazeneca pharmaceuticals lp, sarepta therapeutics, inc., merck sharp & dohme llc, sanofi-aventis u.s. llc, biogen, lumicell, inc., altor bioscience, llc, an indirect wholly-owned subsidiary of immunitybio, inc., daiichi sankyo inc., sumitomo pharma america, inc., u.s. pharmaceuticals, epizyme, inc., glaxosmithkline llc, e.r. squibb & sons, l.l.c. , vertex pharmaceuticals incorporated, deciphera pharmaceuticals, llc, celltrion usa, inc., y-mabs therapeutics, inc., celgene corporation, ge healthcare inc., cephalon, llc, pharmaessentia usa, genmab us, inc., recordati rare diseases, inc., adaptimmune llc, curium us llc, valorum biologics, llc, cordavis limited, coherus oncology, inc., citius pharmaceuticals, inc., gamida cell inc., sandoz inc, mesoblast, sun pharmaceutical industries, inc., onyx pharmaceuticals, inc., advanced accelerator applications usa, inc, cephalon, inc., progenics pharmaceuticals, inc., spectrum pharmaceuticals, inc., springworks therapeutics, inc., sobi, inc., akeso biopharma, co., ltd, amneal pharmaceuticals llc, servier pharmaceuticals llc, juno therapeutics, inc., jazz pharmaceuticals, inc., stemline therapeutics, inc., janssen biotech, inc., pharmacyclics llc, day one biopharmaceuticals, inc., tersera therapeutics llc, bayer healthcare pharmaceuticals inc., taiho pharmaceutical co., ltd., cardinal health 414, llc, accord biopharma inc., kite pharma, inc., syndax pharmaceuticals, inc., aveo pharmaceuticals, inc., kyowa kirin, inc., gilead sciences, inc., janssen products lp, puma biotechnology, inc., alnylam pharmaceuticals, inc., biomarin pharmaceutical inc., on target laboratories, inc., servier pharmaceutical llc, sandoz inc., regeneron pharmaceuticals, inc., genentech inc., biocon biologics inc., immunocore commercial llc, pharmaand gmbh, eisai inc., immunogen, inc., biogen inc., rigel pharmaceuticals, inc., iovance biotherapeutics inc., bio-thera solutions, ltd., btg international inc., iterum therapeutics us limited, genentech, inc., amgen, inc, novartis pharmaceuticals corporation, abbvie inc., seagen inc., janssen biotech, inc, ferring pharmaceuticals inc., viela bio, inc., pfizer laboratories div pfizer inc, array biopharma inc., "
}
      